Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Atovaquone Market Growth 2022-2028

  • LP 4896787
  • 76 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Atovaquone will have significant change from previous year. According to our (LP Information) latest study, the global Atovaquone market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Atovaquone market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Atovaquone market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Atovaquone market, reaching US$ million by the year 2028. As for the Europe Atovaquone landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Atovaquone players cover GSK, Lupin, Apotex, and Amneal Pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Atovaquone market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

250mg

500mg

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospital

Drug Store

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

GSK

Lupin

Apotex

Amneal Pharmaceuticals

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Atovaquone Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Atovaquone by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Atovaquone by Country/Region, 2017, 2022 & 2028

2.2 Atovaquone Segment by Type

2.2.1 250mg

2.2.2 500mg

2.3 Atovaquone Sales by Type

2.3.1 Global Atovaquone Sales Market Share by Type (2017-2022)

2.3.2 Global Atovaquone Revenue and Market Share by Type (2017-2022)

2.3.3 Global Atovaquone Sale Price by Type (2017-2022)

2.4 Atovaquone Segment by Application

2.4.1 Hospital

2.4.2 Drug Store

2.5 Atovaquone Sales by Application

2.5.1 Global Atovaquone Sale Market Share by Application (2017-2022)

2.5.2 Global Atovaquone Revenue and Market Share by Application (2017-2022)

2.5.3 Global Atovaquone Sale Price by Application (2017-2022)

3 Global Atovaquone by Company

3.1 Global Atovaquone Breakdown Data by Company

3.1.1 Global Atovaquone Annual Sales by Company (2020-2022)

3.1.2 Global Atovaquone Sales Market Share by Company (2020-2022)

3.2 Global Atovaquone Annual Revenue by Company (2020-2022)

3.2.1 Global Atovaquone Revenue by Company (2020-2022)

3.2.2 Global Atovaquone Revenue Market Share by Company (2020-2022)

3.3 Global Atovaquone Sale Price by Company

3.4 Key Manufacturers Atovaquone Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Atovaquone Product Location Distribution

3.4.2 Players Atovaquone Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Atovaquone by Geographic Region

4.1 World Historic Atovaquone Market Size by Geographic Region (2017-2022)

4.1.1 Global Atovaquone Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Atovaquone Annual Revenue by Geographic Region

4.2 World Historic Atovaquone Market Size by Country/Region (2017-2022)

4.2.1 Global Atovaquone Annual Sales by Country/Region (2017-2022)

4.2.2 Global Atovaquone Annual Revenue by Country/Region

4.3 Americas Atovaquone Sales Growth

4.4 APAC Atovaquone Sales Growth

4.5 Europe Atovaquone Sales Growth

4.6 Middle East & Africa Atovaquone Sales Growth

5 Americas

5.1 Americas Atovaquone Sales by Country

5.1.1 Americas Atovaquone Sales by Country (2017-2022)

5.1.2 Americas Atovaquone Revenue by Country (2017-2022)

5.2 Americas Atovaquone Sales by Type

5.3 Americas Atovaquone Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Atovaquone Sales by Region

6.1.1 APAC Atovaquone Sales by Region (2017-2022)

6.1.2 APAC Atovaquone Revenue by Region (2017-2022)

6.2 APAC Atovaquone Sales by Type

6.3 APAC Atovaquone Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Atovaquone by Country

7.1.1 Europe Atovaquone Sales by Country (2017-2022)

7.1.2 Europe Atovaquone Revenue by Country (2017-2022)

7.2 Europe Atovaquone Sales by Type

7.3 Europe Atovaquone Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Atovaquone by Country

8.1.1 Middle East & Africa Atovaquone Sales by Country (2017-2022)

8.1.2 Middle East & Africa Atovaquone Revenue by Country (2017-2022)

8.2 Middle East & Africa Atovaquone Sales by Type

8.3 Middle East & Africa Atovaquone Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Atovaquone

10.3 Manufacturing Process Analysis of Atovaquone

10.4 Industry Chain Structure of Atovaquone

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Atovaquone Distributors

11.3 Atovaquone Customer

12 World Forecast Review for Atovaquone by Geographic Region

12.1 Global Atovaquone Market Size Forecast by Region

12.1.1 Global Atovaquone Forecast by Region (2023-2028)

12.1.2 Global Atovaquone Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Atovaquone Forecast by Type

12.7 Global Atovaquone Forecast by Application

13 Key Players Analysis

13.1 GSK

13.1.1 GSK Company Information

13.1.2 GSK Atovaquone Product Offered

13.1.3 GSK Atovaquone Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 GSK Main Business Overview

13.1.5 GSK Latest Developments

13.2 Lupin

13.2.1 Lupin Company Information

13.2.2 Lupin Atovaquone Product Offered

13.2.3 Lupin Atovaquone Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Lupin Main Business Overview

13.2.5 Lupin Latest Developments

13.3 Apotex

13.3.1 Apotex Company Information

13.3.2 Apotex Atovaquone Product Offered

13.3.3 Apotex Atovaquone Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Apotex Main Business Overview

13.3.5 Apotex Latest Developments

13.4 Amneal Pharmaceuticals

13.4.1 Amneal Pharmaceuticals Company Information

13.4.2 Amneal Pharmaceuticals Atovaquone Product Offered

13.4.3 Amneal Pharmaceuticals Atovaquone Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Amneal Pharmaceuticals Main Business Overview

13.4.5 Amneal Pharmaceuticals Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Atovaquone Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Atovaquone Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of 250mg

Table 4. Major Players of 500mg

Table 5. Global Atovaquone Sales by Type (2017-2022) & (K Units)

Table 6. Global Atovaquone Sales Market Share by Type (2017-2022)

Table 7. Global Atovaquone Revenue by Type (2017-2022) & ($ million)

Table 8. Global Atovaquone Revenue Market Share by Type (2017-2022)

Table 9. Global Atovaquone Sale Price by Type (2017-2022) & (USD/Unit)

Table 10. Global Atovaquone Sales by Application (2017-2022) & (K Units)

Table 11. Global Atovaquone Sales Market Share by Application (2017-2022)

Table 12. Global Atovaquone Revenue by Application (2017-2022)

Table 13. Global Atovaquone Revenue Market Share by Application (2017-2022)

Table 14. Global Atovaquone Sale Price by Application (2017-2022) & (USD/Unit)

Table 15. Global Atovaquone Sales by Company (2020-2022) & (K Units)

Table 16. Global Atovaquone Sales Market Share by Company (2020-2022)

Table 17. Global Atovaquone Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Atovaquone Revenue Market Share by Company (2020-2022)

Table 19. Global Atovaquone Sale Price by Company (2020-2022) & (USD/Unit)

Table 20. Key Manufacturers Atovaquone Producing Area Distribution and Sales Area

Table 21. Players Atovaquone Products Offered

Table 22. Atovaquone Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Atovaquone Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Atovaquone Sales Market Share Geographic Region (2017-2022)

Table 27. Global Atovaquone Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Atovaquone Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Atovaquone Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Atovaquone Sales Market Share by Country/Region (2017-2022)

Table 31. Global Atovaquone Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Atovaquone Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Atovaquone Sales by Country (2017-2022) & (K Units)

Table 34. Americas Atovaquone Sales Market Share by Country (2017-2022)

Table 35. Americas Atovaquone Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Atovaquone Revenue Market Share by Country (2017-2022)

Table 37. Americas Atovaquone Sales by Type (2017-2022) & (K Units)

Table 38. Americas Atovaquone Sales Market Share by Type (2017-2022)

Table 39. Americas Atovaquone Sales by Application (2017-2022) & (K Units)

Table 40. Americas Atovaquone Sales Market Share by Application (2017-2022)

Table 41. APAC Atovaquone Sales by Region (2017-2022) & (K Units)

Table 42. APAC Atovaquone Sales Market Share by Region (2017-2022)

Table 43. APAC Atovaquone Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Atovaquone Revenue Market Share by Region (2017-2022)

Table 45. APAC Atovaquone Sales by Type (2017-2022) & (K Units)

Table 46. APAC Atovaquone Sales Market Share by Type (2017-2022)

Table 47. APAC Atovaquone Sales by Application (2017-2022) & (K Units)

Table 48. APAC Atovaquone Sales Market Share by Application (2017-2022)

Table 49. Europe Atovaquone Sales by Country (2017-2022) & (K Units)

Table 50. Europe Atovaquone Sales Market Share by Country (2017-2022)

Table 51. Europe Atovaquone Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Atovaquone Revenue Market Share by Country (2017-2022)

Table 53. Europe Atovaquone Sales by Type (2017-2022) & (K Units)

Table 54. Europe Atovaquone Sales Market Share by Type (2017-2022)

Table 55. Europe Atovaquone Sales by Application (2017-2022) & (K Units)

Table 56. Europe Atovaquone Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Atovaquone Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Atovaquone Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Atovaquone Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Atovaquone Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Atovaquone Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Atovaquone Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Atovaquone Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Atovaquone Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Atovaquone

Table 66. Key Market Challenges & Risks of Atovaquone

Table 67. Key Industry Trends of Atovaquone

Table 68. Atovaquone Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Atovaquone Distributors List

Table 71. Atovaquone Customer List

Table 72. Global Atovaquone Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Atovaquone Sales Market Forecast by Region

Table 74. Global Atovaquone Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Atovaquone Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Atovaquone Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Atovaquone Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Atovaquone Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Atovaquone Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Atovaquone Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Atovaquone Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Atovaquone Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Atovaquone Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Atovaquone Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Atovaquone Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Atovaquone Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Atovaquone Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Atovaquone Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Atovaquone Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Atovaquone Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Atovaquone Revenue Market Share Forecast by Application (2023-2028)

Table 92. GSK Basic Information, Atovaquone Manufacturing Base, Sales Area and Its Competitors

Table 93. GSK Atovaquone Product Offered

Table 94. GSK Atovaquone Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 95. GSK Main Business

Table 96. GSK Latest Developments

Table 97. Lupin Basic Information, Atovaquone Manufacturing Base, Sales Area and Its Competitors

Table 98. Lupin Atovaquone Product Offered

Table 99. Lupin Atovaquone Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 100. Lupin Main Business

Table 101. Lupin Latest Developments

Table 102. Apotex Basic Information, Atovaquone Manufacturing Base, Sales Area and Its Competitors

Table 103. Apotex Atovaquone Product Offered

Table 104. Apotex Atovaquone Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 105. Apotex Main Business

Table 106. Apotex Latest Developments

Table 107. Amneal Pharmaceuticals Basic Information, Atovaquone Manufacturing Base, Sales Area and Its Competitors

Table 108. Amneal Pharmaceuticals Atovaquone Product Offered

Table 109. Amneal Pharmaceuticals Atovaquone Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 110. Amneal Pharmaceuticals Main Business

Table 111. Amneal Pharmaceuticals Latest Developments

List of Figures

Figure 1. Picture of Atovaquone

Figure 2. Atovaquone Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Atovaquone Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Atovaquone Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Atovaquone Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of 250mg

Figure 10. Product Picture of 500mg

Figure 11. Global Atovaquone Sales Market Share by Type in 2021

Figure 12. Global Atovaquone Revenue Market Share by Type (2017-2022)

Figure 13. Atovaquone Consumed in Hospital

Figure 14. Global Atovaquone Market: Hospital (2017-2022) & (K Units)

Figure 15. Atovaquone Consumed in Drug Store

Figure 16. Global Atovaquone Market: Drug Store (2017-2022) & (K Units)

Figure 17. Global Atovaquone Sales Market Share by Application (2017-2022)

Figure 18. Global Atovaquone Revenue Market Share by Application in 2021

Figure 19. Atovaquone Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Atovaquone Revenue Market Share by Company in 2021

Figure 21. Global Atovaquone Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Atovaquone Revenue Market Share by Geographic Region in 2021

Figure 23. Global Atovaquone Sales Market Share by Region (2017-2022)

Figure 24. Global Atovaquone Revenue Market Share by Country/Region in 2021

Figure 25. Americas Atovaquone Sales 2017-2022 (K Units)

Figure 26. Americas Atovaquone Revenue 2017-2022 ($ Millions)

Figure 27. APAC Atovaquone Sales 2017-2022 (K Units)

Figure 28. APAC Atovaquone Revenue 2017-2022 ($ Millions)

Figure 29. Europe Atovaquone Sales 2017-2022 (K Units)

Figure 30. Europe Atovaquone Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Atovaquone Sales 2017-2022 (K Units)

Figure 32. Middle East & Africa Atovaquone Revenue 2017-2022 ($ Millions)

Figure 33. Americas Atovaquone Sales Market Share by Country in 2021

Figure 34. Americas Atovaquone Revenue Market Share by Country in 2021

Figure 35. United States Atovaquone Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Atovaquone Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Atovaquone Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Atovaquone Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Atovaquone Sales Market Share by Region in 2021

Figure 40. APAC Atovaquone Revenue Market Share by Regions in 2021

Figure 41. China Atovaquone Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Atovaquone Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Atovaquone Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Atovaquone Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Atovaquone Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Atovaquone Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Atovaquone Sales Market Share by Country in 2021

Figure 48. Europe Atovaquone Revenue Market Share by Country in 2021

Figure 49. Germany Atovaquone Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Atovaquone Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Atovaquone Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Atovaquone Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Atovaquone Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Atovaquone Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Atovaquone Revenue Market Share by Country in 2021

Figure 56. Egypt Atovaquone Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Atovaquone Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Atovaquone Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Atovaquone Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Atovaquone Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Atovaquone in 2021

Figure 62. Manufacturing Process Analysis of Atovaquone

Figure 63. Industry Chain Structure of Atovaquone

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390